229 related articles for article (PubMed ID: 23238704)
1. Serum paraoxonase, arylesterase activity, and oxidative status in patients with nasal polyp.
Hao W; Zhu Y; Meng L; Ni C; Yang J; Zhou H
Eur Arch Otorhinolaryngol; 2013 May; 270(6):1861-5. PubMed ID: 23238704
[TBL] [Abstract][Full Text] [Related]
2. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with chronic adenotonsillitis.
Koc S; Aksoy N; Bilinc H; Duygu F; Uysal IÖ; Ekinci A
Int J Pediatr Otorhinolaryngol; 2011 Nov; 75(11):1364-7. PubMed ID: 21893350
[TBL] [Abstract][Full Text] [Related]
3. Serum paraoxonase, arylesterase activities and oxidative status in patients with insomnia.
Liang B; Li YH; Kong H
Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2517-22. PubMed ID: 24089233
[TBL] [Abstract][Full Text] [Related]
4. Serum paraoxonase and arylesterase activity and oxidative status in patients with multiple sclerosis.
Kirbas A; Kirbas S; Anlar O; Efe H; Yilmaz A
J Clin Neurosci; 2013 Aug; 20(8):1106-9. PubMed ID: 23669169
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress markers in severe preeclampsia and preeclampsia-related perinatal morbidity - preliminary report.
Oztas E; Ozler S; Tokmak A; Erel O; Ergin M; Uygur D; Danisman N
Ginekol Pol; 2016; 87(6):436-41. PubMed ID: 27418221
[TBL] [Abstract][Full Text] [Related]
6. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
7. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
[TBL] [Abstract][Full Text] [Related]
8. Blood and semen paraoxonase-arylesterase activities in normozoospermic and azoospermic men.
Gulum M; Gumus K; Yeni E; Dogantekin E; Ciftci H; Akin Y; Savas M; Altunkol A
Andrologia; 2017 Nov; 49(9):. PubMed ID: 28000956
[TBL] [Abstract][Full Text] [Related]
9. Paraoxonase and arylesterase activity and total oxidative/anti-oxidative status in patients with idiopathic Parkinson's disease.
Kirbas A; Kirbas S; Cure MC; Tufekci A
J Clin Neurosci; 2014 Mar; 21(3):451-5. PubMed ID: 24145052
[TBL] [Abstract][Full Text] [Related]
10. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.
Tabur S; Korkmaz H; Eren MA; Oğuz E; Sabuncu T; Aksoy N
J Diabetes Complications; 2015; 29(1):115-9. PubMed ID: 25179234
[TBL] [Abstract][Full Text] [Related]
11. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
Tabur S; Torun AN; Sabuncu T; Turan MN; Celik H; Ocak AR; Aksoy N
Eur J Endocrinol; 2010 Mar; 162(3):535-41. PubMed ID: 20022940
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Serum Paraoxonase, Arylesterase, Prolidase Activities and Oxidative Stress in Patients with Alopecia Areata.
Dizen-Namdar N; Emel Kocak F; Kidir M; Sarici G; Tak H; Altuntas I
Skin Pharmacol Physiol; 2019; 32(2):59-64. PubMed ID: 30544126
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and severity of coronary artery disease in young smokers with acute myocardial infarction.
Aksoy S; Cam N; Gurkan U; Oz D; Özden K; Altay S; Durmus G; Agirbasli M
Cardiol J; 2012; 19(4):381-6. PubMed ID: 22825899
[TBL] [Abstract][Full Text] [Related]
14. Total antioxidant and total oxidant states, and serum paraoxonase-1 in neonatal sepsis.
Annagür A; Örs R; Altunhan H; Kurban S; Ertuğrul S; Konak M; Uygun SS; Pekcan S; Erbay E; Mehmetoğlu İ
Pediatr Int; 2015 Aug; 57(4):608-13. PubMed ID: 25488411
[TBL] [Abstract][Full Text] [Related]
15. Decreased paraoxonase 1, arylesterase enzyme activity, and enhanced oxidative stress in patients with mitral and aortic valve insufficiency.
Yilmaz N; Simsek N; Aydin O; Yardan E; Aslan S; Eren E; Yegin A; Buyukbas S
Clin Lab; 2013; 59(5-6):597-604. PubMed ID: 23865359
[TBL] [Abstract][Full Text] [Related]
16. Paraoxonase and arylesterase activities in fibromyalgia.
Altindag O; Gur A; Calgan N; Soran N; Celik H; Selek S
Redox Rep; 2007; 12(3):134-8. PubMed ID: 17623520
[TBL] [Abstract][Full Text] [Related]
17. Multiple myeloma: relationship to antioxidant esterases.
Ellidag HY; Eren E; Aydin O; Yıldırım M; Sezer C; Yilmaz N
Med Princ Pract; 2014; 23(1):18-23. PubMed ID: 24216973
[TBL] [Abstract][Full Text] [Related]
18. High Prolidase Levels may be a Marker of Irreversible Extracellular Matrix Changes in Controlled Acromegaly Patients?
Tabur S; Sezen H; Korkmaz H; Ozkaya M; Akarsu E
Exp Clin Endocrinol Diabetes; 2016 Feb; 124(2):82-6. PubMed ID: 26575119
[TBL] [Abstract][Full Text] [Related]
19. Increased oxidative stress in children with attention deficit hyperactivity disorder.
Sezen H; Kandemir H; Savik E; Basmacı Kandemir S; Kilicaslan F; Bilinc H; Aksoy N
Redox Rep; 2016 Nov; 21(6):248-53. PubMed ID: 26886057
[TBL] [Abstract][Full Text] [Related]
20. The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters.
Horoz M; Kiykim AA; Cimen B; Erdem A
Artif Organs; 2011 Oct; 35(10):923-9. PubMed ID: 21517907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
